MGI(SH:688114) Xin Lang Cai Jing·2025-10-14 02:48Core Viewpoint - BGI Genomics experienced a stock price decline of 2.03% on October 14, 2023, with a current price of 70.88 CNY per share and a total market capitalization of 29.523 billion CNY [1] Financial Performance - Year-to-date, BGI Genomics' stock price has increased by 51.49%, with a 5-day increase of 5.78%, a 20-day decrease of 1.16%, and a 60-day increase of 12.96% [2] - For the first half of 2025, BGI Genomics reported a revenue of 1.114 billion CNY, a year-on-year decrease of 7.90%, while the net profit attributable to shareholders was -104 million CNY, showing a year-on-year increase of 65.28% [2] Shareholder Information - As of June 30, 2025, BGI Genomics had 13,500 shareholders, an increase of 7.64% from the previous period, with an average of 15,766 circulating shares per shareholder, a decrease of 7.09% [2] - The company has distributed a total of 150 million CNY in dividends since its A-share listing [3] Institutional Holdings - As of June 30, 2025, the second-largest circulating shareholder is the Huaxia SSE Sci-Tech Innovation Board 50 ETF, holding 11.5323 million shares, a decrease of 245,600 shares from the previous period [3] - The sixth-largest shareholder is the E Fund SSE Sci-Tech Innovation Board 50 ETF, holding 8.6237 million shares, an increase of 243,600 shares [3] - The seventh-largest shareholder is the Hua Bao CSI Medical ETF, holding 7.0399 million shares, an increase of 17,600 shares [3]